Tunisia approves Johnson & Johnson COVID-19 vaccine

0
132
UKRAINE - 2021/02/05: In this photo illustration a Johnson & Johnson logo is seen in front of a medical syringe and a vial with coronavirus vaccine. Johnson & Johnson (J&J) has asked regulators to authorize their COVID-19 vaccine for emergency use in the U.S. and also will apply to authorize to EU, reportedly by media. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Tunisia approved Johnson & Johnson’s COVID-19 vaccine on Thursday and will soon receive 1.5 million doses of the vaccine under an African Union plan.

The North Africa country also intends to buy further doses directly from the company to speed up its vaccination campaign, as it seeks to vaccinate 5 million people by the end of the year.

Tunisia will extend its nighttime curfew hours and will prevent all gatherings and weekly markets to curb the rapid spread of the coronavirus pandemic, as intensive care units near-maximum capacity in most hospitals.

Leave a Reply